Lv3
400 积分 2025-10-24 加入
Optimizing In Vivo CAR-T Cell Engineering for Cancer Immunotherapy
12天前
已完结
Tolerability of hypertonic injectables
15天前
已完结
If Euhydric and Isotonic Do Not Work, What Are Acceptable pH and Osmolality for Parenteral Drug Dosage Forms?
16天前
已完结
Versatility of LNPs across different administration routes for targeted RNA delivery
20天前
已完结
Advancing nanoparticle delivery studies: flow cytometry-based quantification of nanoparticle uptake and transfection in retinal tissue
22天前
已完结
Comparison of Three Antihapten VHH Selection Strategies for the Development of Highly Sensitive Immunoassays for Microcystins
26天前
已完结
Fluorinated lipid nanoparticles enable real-time tracking of mRNA delivery and uncover spatiotemporal mechanisms of immune activation
1个月前
已完结
Tumor mRNA-lipid nanoparticles via chimeric nanobody-lipid co-assembly
1个月前
已完结
Abstract 6119: Efficient generation of active CAR-T cells from healthy donors and lymphoma patients
1个月前
已关闭
皖公网安备34019202002308
